Anti-Alzheimers

Curcumin (diferuloyl methane) is the main pigment of turmeric. It is widely used as a colorant and preservative agent. No data regarding its daily intake in western countries are available intake may reach 80 to 200 mg in adult Indians. To date, no study has explored the effect of curcumin consumption on the incidence of diseases, but many beneficial effects on health have been reported in cell and animal models. These include anti-carcinogenic, anti-diabetic, anti-atherosclerotic, and anti-Alzheimer s disease properties. ... 

Figure 13.3. An overview of the chemical events at a cholinergic synapse and agents commonly used to alter cholinergic transmission acetyl CoA, acetyl coenzyme A Ch, choline. Nicotine and scopolamine bind to nicotinic and muscarinic receptors, respectively (nicotine is an agonist while scopolamine is an antagonist). Most anti-Alzheimer drugs inhibit the action of the enzyme cholinesterase.

Table 13.4. The current state of development of selected anti-Alzheimer drugs.

Galanthamine (10) Galanthus woronowii Losinsk (snowdrop) Anti-Alzheimer s disease... 

Viegas C, Jr., da Bolzani VS, Barreiro EJ, Fraga CA, New anti-Alzheimer drugs from biodiversity The role of the natural acetylchofinesterase inhibitors,... 

Memantine (Namenda) [Anti Alzheimer Agent/NMDA Receptor Antagonist] Uses Mod/ evere Alzheimer Dz Action N-methyl-D-aspartate recqjtor antagonist Dose Target 20 mg/d, start 5 mg/d, t 5 mg/d to 20 mg/d, wait >1 wk before t dose use doses if >5mg/d Caution [B, /-] Hqjatic/mild-mod renal impair Disp Tabs, sol SE Dizziness Interactions t Effects W amantadine, carbonic anhydrase inhibitors, dextromethorphan, ketamine, Na bicarbonate t effects W/ any drug, herb, food that alkalinizes urine EMS Use NaHCOs w/ caution OD May cause restlessness, hallucinations, drowsiness, and fainting symptomatic and supportive... 

Rivastigmine Transdermal (Exelon Patch) [Cholinesterase Inhibitor/Anti-Alzheimer Agent] Uses MUd/mod Alzheimer and Parkinson Dz dementia Action Acetylcholinesterase inhibitor Dose Initial 4.6-mg patch/d applied to back, chest, upper arm, T 9.5 mg after 4 wk if tolCTated Caution [ ] Sick sinus synd, conduction defects, asthma, COPD, urinary obst, Sz Contra Hypersensitivity to rivastigmine, other carbamates Disp Transdermal patch 5 cm (4.6 mg/24 h), 10 cm (9.5 mg/24 h) SE NA /D EMS See Rivastigmine OD See Rivastigmine... 

AUain H, Bentue-Ferrer D, Zekri O, Schuck S, Lebreton S, Reymann JM. Experimental and clinical methods in the development of anti-Alzheimer drugs. Fund Chn Pharmacol 1998 12 13-29. 

To test the feasibility of enzyme-catalyzed enantiosective reactions in solid/gas reactors and to evaluate the efficiency of the resolution obtained in the gas phase compared to liquid systems, resolution of racemic 2-pentanol, catalyzed by CALB, through alcoholysis with methyl propanoate as acyl donor has been investigated in both liquid media and the gas phase [24]. As CALB has an enantiopreference for R enantiomers of secondary alcohols, this last reaction leads to S-2-Pentanol. This compound is a chiral intermediate in the synthesis of several potential anti-Alzheimer s drugs that inhibit 3-amyloid peptide release and/or its synthesis [25]. The degree of enantioselectivity was measured by using the enantiomeric ratio E, which is defined as the ratio of the specificity constants kcat/KM for the enantiomers (R/S in this case). E can be determined from the enantiomeric excess of... 

An enantiospecific synthesis of the potent anti-Alzheimer s agent (-t-)-ferruginine 1 and two enantiospecific syntheses of the potent anti-Alzheimer s agent anatoxin-a 2 were submitted essentially simultaneously earlier this year. In each case, the starting material used was the inexpensive pyroglutamic acid 3, and in each case the synthesis depended on Ru-catalyzed alkyne-alkene metathesis. 

IV. Anti-Alzheimer s Activity A. Pathogenic mechanism of AD Amyloid 58... 

Bioactive peptides as products of hydrolysis of diverse marine invertebrate (shellfish, crustacean, rotifer, etc.) proteins are the focus of current research. After much research on these muscles and byproducts, some biologically active peptides were identified and applied to useful compounds for human utilization. This chapter reviews bioactive peptides from marine invertebrates in regarding to their bioactivities. Additionally, specific characteristics of antihypertensive, anti-Alzheimer, antioxidant, antimicrobial peptide enzymatic production, methods to evaluate bioactivity capacity, bioavailability, and safety concerns of peptides are reviewed. 

Memantine (Namenda) [Anti-Alzheimer Agent/NMDA Receptor Antagonist] Uses Mod/severe Alzheimer Dz Action N-... 

Drucker s example uses changes in population (i.e. size/young adults the third world) age structure especially more elderly people distribution between town and country more women in employment more in further/higher education higher disposable income. With little analysis consequences are predictable. For chemistry opportunity lies with medicines for the aged e.g. anti Alzheimer s disease, life style drugs and nutriceuticals. 

Bar-On P, et al. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry, 2002, 41(11),... 

The contribution of plants to modern medicine can hardly be overstated. Many plant natural products are used in medicine in their native, undomesticated form and the anti-Alzheimer s alkaloid galanthamine and the anticancer diterpenoid paclitaxel are additions to the inventory of plant-derived drugs obtained by direct isolation.101... 

Camps P, Formosa X, Galdeano C et al (2009) Pyrano[3, 2-c]qionoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and P-amyloid-drrected anti-Alzheimer compounds. J Med Chem 52 5365-5379... 

In fact, the enantiospecific syntheses of the two potent anti-Alzheimer s agents like (+)-ferruginine (Aggarwal et al. 2004), a tropane ring system, and two enantiospecific syntheses of the anatoxin-a, were submitted essentially simultaneously at the beginning of 2004 (Mori et al. 2004 Brermeman and... 

Exposure to a toxic dose of OP results in inhibition of acetylcholinesterase and butyrylcholinesterase activities. The most common method to measure OP exposure is to assay acetylcholinesterase and butyrylcholinesterase activities in blood using a spectrophotometric method (EUman et al, 1961 Wilson et al, 2005 Worek et al, 1999). The drawbacks of activity assays are that they do not identily the OP. They show that the poison is a cholinesterase inhibitor but do not distinguish between nerve agents, OP pesticides, carbamate pesticides, and tightly bound, noncovalent inhibitors like tacrine and other anti-Alzheimer drugs. In addition, low-dose exposure, which inhibits less than 20% of the cholinesterase, carmot be determined by measuring acetylcholinesterase and butyrylcholinesterase activity because individual variability in activity levels is higher than the percent inhibition. 

Figure 2.2 Common scaffold, with standardized numbering of atoms for which electrotopological state atom indices (ETSA), sensitive to the perturbations induced by the substituents R1-R5, were calculated and used in QSAR modeling. The study overhastily concluded that phenyl rings A and B must be part of the pharmacophore, explaining anti-Alzheimer activity, because the QSAR study picked the average ETSA values of the atoms within the rings as key descriptors.

Kryger, G., Silman, I., Sussman, J. L. Structure of Acetylcholinesterase Complexed with F2020 (Aricept) Implications for the Design of New Anti-Alzheimer Drugs, Structure Fold. Des. 1999, 15, 297-307. 

Other broad-based examples besides that of asthma could surely be found. However, there are other established though more restricted examples. Well known is the failure of treatment of Alzheimer s disease by tacrin if the patient has a variant of ApoE4, an apoli-poprotein. Tacrin is a cholinesterase inhibitor, one of the first anti-Alzheimer drugs,chosen to elevate... 

Phenserine (252), a selective inhibitor of acetylcholinesterase with minimal effect on butyrylcholinesterase, was cited as a possible anti-Alzheimer drug (319). 

Anticonvulsants, Cards 116-122 Anti-Parkinson s and Anti-Alzheimer s Agents, Cards 1 23-1 30 Affecting Mental Health, Cards 131-142 Stimulants, Cards 143-151... 

Central Nervous System Drugs Anti-Parkinson s and Anti-Alzheimer s Agents... 

---